Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000083192 | SCV000299863 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 1 | 2016-09-08 | reviewed by expert panel | curation | Variant allele predicted to encode a truncated non-functional protein. |
Ambry Genetics | RCV002433543 | SCV002751961 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-07-16 | criteria provided, single submitter | clinical testing | The c.2955delC pathogenic mutation, located in coding exon 9 of the BRCA1 gene, results from a deletion of one nucleotide at nucleotide position 2955, causing a translational frameshift with a predicted alternate stop codon (p.I986Sfs*14). This alteration was identified in an individual diagnosed with triple negative breast cancer at the age of 27 (Robertson L et al. Br J Cancer, 2012 Mar;106:1234-8). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Labcorp Genetics |
RCV003529961 | SCV004296823 | pathogenic | Hereditary breast ovarian cancer syndrome | 2023-09-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile986Serfs*14) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with breast cancer (PMID: 22333603). ClinVar contains an entry for this variant (Variation ID: 54731). For these reasons, this variant has been classified as Pathogenic. |
Sharing Clinical Reports Project |
RCV000083192 | SCV000115266 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 1 | 2013-04-03 | no assertion criteria provided | clinical testing |